Elastofibroma dorsi: evaluating the sufficiency of magnetic resonance in diagnosis and the time of surgical treatment
Background: Elastofibroma dorsi is a rarely seen fibroelastic pseudotumor. While radiological evaluation can be best done with magnetic resonance imaging (MRI), biopsy may be additionally required in diagnosis. Surgical excision of the tumor is recommended in painful cases, however, many cases can be treated and followed with conservative methods. In our study, we evaluated the features and sufficiency of MRI in diagnosis, the growth extent of the masses and the need for surgical treatment.Methods: Eight lesions of the five patients diagnosed and followed up in our clinic between the years 2014 and 2017 were included in the study. All patients were female and had a mean age of 60.4 (50-68). Lesions were bilaterally located in three patients. Seven lesions were diagnosed with MRI and one was diagnosed with biopsy. The size of the lesions at the time of diagnosis and final follow-up and differences in the radiological features were evaluated by the same experienced radiologist using MRI. Complaints of the patients were evaluated, and their clinical examinations were performed.Results: The mean period of follow-up was 22.4 (8-42) months. The masses had a mean diameter of 59.5 (40-75)mm in the craniocaudal plane and 59.4 (40-70) x 22.4 (10-36)mm in the axial plane at the time of diagnosis and a mean diameter of 60.5 (40-75)mm in the craniocaudal plane and 61 (43-70) x 22.6 (10-36)mm in the axial plane at the final follow-up. At the final follow-up, two patients had three lesions without pain and three patients had five lesions with mild pain. No movement limitation was observed.Conclusions: Typical MRI findings were observed in all lesions (including the one that was performed biopsy) and biopsy was not planned for the lesions with typical findings. All lesions were followed by conservative management and no discontent was reported by the patients. Surgical treatment was planned in case of severe pain, rapid growth and advanced clinical symptoms.